文献速递神经肌肉病

腓骨肌萎缩症4J型的临床特征

Clinical Characteristics of Charcot-Marie-Tooth Disease Type 4J.
PubMed 文献 · Neurology · 2024-08-12

本研究为横断面研究,纳入19例经基因确诊的腓骨肌萎缩症4J型(CMT4J)儿童和成人患者,评估CMT特异性结局指标及探索性生物标志物。最常见表现为粗大运动延迟和远端重于近端的肌无力(14/19例),认知和呼吸障碍各见于8/19例;神经丝轻链水平与儿童CMT评分(CMTPedS)呈显著正相关。

要点

  • CMT4J常见粗大运动延迟和远端重于近端的肌无力(14/19例)。
  • 认知和呼吸障碍各见于8/19例,为常见非神经肌肉表现。
  • 6例患者神经传导速度非均匀性减慢,2例肌无力不对称。

核心结论

  • CMT4J最常见的临床表现为运动延迟、肌无力以及呼吸和认知障碍。
  • 儿童人群中神经丝轻链水平与CMTPedS评分相关。
  • 本研究显示CMTPedS等临床结局用于评估儿童患者疾病严重程度具有可行性,并提供了神经丝轻链和肌肉MRI脂肪分数的基线特征。

研究设计与样本

  • 横断面研究,通过遗传性神经病联盟网络招募经基因确诊的CMT4J儿童和成人患者,要求FIG4基因存在2个致病变异。
  • 共纳入19例患者,包括14例儿童(平均年龄10.9±3.9岁)和5例成人(平均年龄40.0±13.9岁)。
  • 采用标准化CMT特异性结局指标和探索性生物标志物(肌肉MRI脂肪分数、电生理、神经丝轻链水平)评估疾病严重程度,并进行描述性统计和相关性分析。

主要发现

  • 粗大运动延迟和远端重于近端的肌无力见于14/19例患者。
  • 认知和呼吸障碍各见于8/19例患者。
  • 2例患者肌无力不对称,6例患者神经传导速度非均匀性减慢。
  • 多数患者CMTPedS、儿童生活质量量表(Pediatric Quality of Life Inventory)和Vineland适应行为量表评分受影响。
  • 神经丝轻链水平与CMTPedS呈显著正相关,但研究把握度不足,未能观察到CMTPedS与MRI脂肪分数的相关性。

局限性

  • 研究把握度不足,未能观察到CMTPedS与MRI脂肪分数的相关性。
  • 冠状病毒病2019(COVID-19)大流行影响部分访视,导致部分评估数量减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Charcot-Marie-Tooth disease type 4J (CMT4J) is caused by autosomal recessive variants in the Factor-Induced Gene 4 (FIG4) gene. Recent preclinical work has demonstrated the feasibility of adeno-associated virus serotype 9-FIG4 gene therapy. This study aimed to further characterize the CMT4J phenotype and evaluate feasibility of validated CMT-related outcome measures for future clinical trials. METHODS: This cross-sectional study enrolled children and adults with genetically confirmed CMT4J, with 2 documented disease-causing variants in the FIG4 gene. Patients were recruited through the Inherited Neuropathy Consortium network. Disease severity was assessed using standardized CMT-specific outcome measures and exploratory biomarkers including muscle MRI fat fraction, electrophysiology, and neurofilament light chain levels. Descriptive statistics and correlation analyses were conducted to explore relationships between variables. RESULTS: We recruited a total of 19 patients, including 14 pediatric patients (mean age 10.9 ± 3.9 years) and 5 adults (mean age 40.0 ± 13.9 years). The most frequent symptoms were gross motor delay and distal more than proximal muscle weakness, which were observed in 14 of 19 patients. The most common non-neuromuscular symptoms were cognitive and respiratory deficits, each seen in 8 of 19 patients. We denoted asymmetric weakness in 2 patients and nonuniform slowing of conduction velocities in 6 patients. Charcot-Marie-Tooth Disease Pediatric Scale (CMTPedS), Pediatric Quality of Life Inventory, and Vineland Adaptive Behavior Scale scores were affected in most patients. We observed a significant positive correlation between neurofilament light chain levels and CMTPedS, but the study was underpowered to observe a correlation between CMTPedS and MRI fat fraction. DISCUSSION: We obtained baseline clinical and biomarker data in a broad cohort with CMT4J in pediatric and adult patients. Motor delay, muscle weakness, and respiratory and cognitive difficulties were the most common clinical manifestations of CMT4J. Many patients had nerve conduction studies with nonuniform slowing, and 2 had an asymmetric pattern of muscle weakness. We observed that the neurofilament light chain levels correlated with the CMTPedS in the pediatric population. This study showed feasibility of clinical outcomes including CMTPedS in assessment of disease severity in the pediatric patient population and provided baseline characteristics of exploratory biomarkers, neurofilament light chain levels, and muscle MRI fat fraction. The coronavirus disease 2019 pandemic affected some of the visits, resulting in a reduced number of some of the assessments.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Sadjadi R, Picher-Martel V, Morrow JM, et al. Clinical Characteristics of Charcot-Marie-Tooth Disease Type 4J. Neurology. 2024. PMID: 39133880. doi:10.1212/WNL.0000000000209763

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。